Header cover image

Pharmaceuticals & Biotech Biotech Breakthroughs

Results

50

0 new

Companys with strong funding and high growth potential

50 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

0M40

Zynerba Pharmaceuticals
US$1.314.0%65.7%US$65.6mUS$1.26PB2.3xE67.2%n/a

FYBD

Formycon
€63.300%-11.1%€911.0m€118.80PS13.3xE80.8%n/a

BINVS

BioInvent International
SEK 34.750%n/aSEK 2.1bSEK 124.66PS6.7xE64.4%n/a

0JXI

Madrigal Pharmaceuticals
US$214.08-13.2%42.2%US$4.7bUS$360.87PS317.3xE68.1%n/a

LLAI

LungLife AI
UK£0.12-6.1%-87.2%UK£3.5mUK£1.71PS163.1xE101.0%n/a

0XOD

UroGen Pharma
US$12.87-8.5%-9.3%US$541.6mUS$43.49PS6.3xE55.1%n/a

BSLNz

Basilea Pharmaceutica
CHF 47.253.1%15.1%CHF 570.9mCHF 73.43PS3.8xE34.4%0%

0QCO

Pharming Group
€0.710.4%-40.5%€482.3m€1.78PS1.9xE64.6%n/a

0YAY

Vitrolife
SEK 252.004.4%75.9%SEK 34.1bSEK 272.10PS9.6xE105.9%0.4%

0O9B

Almirall
€8.843.2%-6.6%€1.9b€11.67PS2xE50.7%2.1%

APPHD

Apontis Pharma
€6.370%n/a€72.1m€12.87PS2xE78.7%n/a

DBVP

DBV Technologies
€3.610%n/a€284.7m€7.52PS59.3xE42.1%n/a

0QZU

Vertex Pharmaceuticals
US$465.03-3.9%31.9%US$119.2bUS$511.89PS11.6xE46.4%n/a

PPGNZ

PolyPeptide Group
CHF 31.70-1.3%92.0%CHF 1.0bCHF 26.98PS3.4xE67.0%0%

HCM

HUTCHMED (China)
UK£2.747.5%-1.3%UK£2.3bUK£4.52PS5.1xE48.2%n/a

0J8Z

Illumina
US$129.15-4.7%-2.3%US$20.1bUS$145.71PS4.8xE75.6%n/a

PHOO

Photocure
NOK 57.700%n/aNOK 1.8bNOK 80.62PS3.9xE139.2%0%

ALME

Almirall
€9.590%n/a€1.8b€12.90PS2xE50.7%2.1%

0IGA

Emergent BioSolutions
US$6.99-2.7%122.4%US$320.9mUS$7.69PB1xE106.4%n/a

0IRF

Evotec
€6.13-4.1%-66.7%€1.1b€13.71PS1.4xE73.4%n/a

0LKB

Vanda Pharmaceuticals
US$4.885.4%8.8%US$282.7mUS$8.31PS1.5xE79.7%n/a

VITRS

Vitrolife
SEK 220.000%n/aSEK 32.8bSEK 237.49PS9.3xE105.8%0.4%

0AAJ

PolyPeptide Group
CHF 31.80-1.2%91.1%CHF 1.0bCHF 27.06PS3.4xE67.0%0%

EVTD

Evotec
€5.200%-72.8%€1.0b€12.03PS1.3xE73.3%n/a
Page 2 of 3
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.